XENETIC BIOSCIENCES, INC. Goodwill, Acquired During Period
XENETIC BIOSCIENCES, INC. (XBIO) reported Goodwill, Acquired During Period of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2020-03-26
- XENETIC BIOSCIENCES, INC. goodwill, acquired during period for the quarter ending 2014-12-31 was $180.00.
- XENETIC BIOSCIENCES, INC. goodwill, acquired during period for the quarter ending 2014-03-31 was $4.13M.
- XENETIC BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2019 was $0.00.
- XENETIC BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2018 was $0.00.
- XENETIC BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2017 was $0.00.
- XENETIC BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2016 was $0.00.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-26 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-30 | |||
| 2014-12-31 | $180.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.13M 10-K · filed 2016-03-30 | $4.13M 10-K · filed 2015-04-15 | |
| 2014-09-30 | $4.13M 10-Q · filed 2014-11-14 | |||
| 2014-03-31 | $4.13M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $3.40M 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |